Center-Authored Papers

Filters: Author is Noguchi, Lisa  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Vaccine and Infectious Disease Division
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Beigi R, Noguchi L, Parsons T, Macio I, Kunjara Na Ayudhya RP, Chen J, Hendrix CW, Masse B, Valentine M, Piper J et al..  2011.  Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.. The Journal of infectious diseases. 204(10):1527-31. Abstract
United States
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
TIME
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Therapeutic Equipoise
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Social Marketing
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
September 2011
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Residence Characteristics
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Questionnaires
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Pre-Exposure Prophylaxis
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Organophosphonates
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
October 2011
Beigi R, Noguchi L, Parsons T, Macio I, Kunjara Na Ayudhya RP, Chen J, Hendrix CW, Masse B, Valentine M, Piper J et al..  2011.  Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.. The Journal of infectious diseases. 204(10):1527-31. Abstract
National Institutes of Health (U.S.)
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Middle Aged
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Medication Adherence
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Humans
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
HIV-1
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
HIV Seropositivity
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
HIV Infections
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Health Promotion
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Health Knowledge, Attitudes, Practice
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract
Health Education
White R, Chileshe M, Dawson L, Donnell D, Hillier S, Morar N, Noguchi L, Dixon D.  2011.  Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa.. Clinical trials (London, England). 8(1):103-11. Abstract